Perry, Pamela

Otsuka (United States) · Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)

2 papers on CoChatORCID 0000-0002-1203-123X

Most cited papers

Verified
Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study
Calabrese, J. R., Sanchez, R., Jin, N., Amatniek, J., Cox, K., Johnson, B., Perry, P., Hertel, P., Such, P., Salzman, P. M., et al. (2017) · The Journal of Clinical Psychiatry
Bipolar Disorder and TreatmentSchizophrenia research and treatment
Cited by 135
Verified
The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study
Citrome, L., Ota, A., Nagamizu, K., Perry, P., Weiller, E., & Baker, R. A. (2016) · International Clinical Psychopharmacology
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 74

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free